Abstract: A method is provided for inhibiting free radical degradation in the skin of a human or nonhuman animal comprising contacting the skin with a skin treatment composition having a concentration of a 1-(3-methoxybenzyl)-3-substituted thiourea compound effective for inhibiting free radical generation. Skin protecting compositions comprising a free radical inhibiting concentration of a 1-(3-methoxybenzyl)-3-substituted thiourea compound, and optionally a sunscreeen composition, are also provided.
Abstract: This invention relates to a novel lipid composition for use in cosmetics capable of increasing moisture-keeping ability or barrier function of the stratum corneum, protecting the skin and improving dry or rough skin, and to products which use the same, such as cosmetics and medicaments. Particularly, it relates to a lipid composition which comprises at least one component (A) selected from the group consisting of a 2-acylaminoalkane-1,3-diol and optically active compounds thereof, at least one component (B) selected from the group consisting of a 2-acylaminoalkane-1,3-diol in which at least one of the &agr;-position and &bgr;-position of the acyl group is substituted with hydroxyl group and optically active compounds thereof and at least one component (C) selected from sterols, wherein the components (A), (B) and (C) are mixed at a ratio that constructs a liquid crystal structure, and to products which contain the lipid composition, such as cosmetics and medicaments.
Type:
Grant
Filed:
June 6, 2001
Date of Patent:
March 4, 2003
Assignee:
Takasago International Corporation
Inventors:
Izumi Kawada, Kenya Ishida, Kiyohito Sawano, Toshimitsu Hagiwara
Abstract: A controlled release microcapsule pharmaceutical formulation for burst-free, sustained, programmable release of a non-steroidal, antiinflammatory drug over a duration from 24 hours to 2 months, comprising: a non-steroidal, antiinflammatory drug and a blend of biocompatible, biodegradable poly (lactide/glycolide).
Type:
Grant
Filed:
November 20, 2000
Date of Patent:
March 4, 2003
Assignee:
The United States of America as represented by the Secretary
of the Army
Inventors:
William M. Vaughn, John E. Van Hamont, Jean A. Setterstrom
Abstract: Non-hydroxyalkylated cyclodextrins are disclosed wherein at least one primary alcohol function (CH2OH) is substituted, the —OH portion being replaced by a substituent with formula —O—CO—R or —NR1R2, where:
R, R1 and R2 independently represent a linear or cyclic, saturated or unsaturated, hydroxylated or non-hydroxylated alkyl group containing 1 to 30 carbon atoms, preferably 1 to 22 carbon atoms, more preferably a fatty chain containing 2 to 22 carbon atoms. These cyclodextrins are used as vectors for at least one active ingredient, in particular to encourage tissue penetration, in a cosmetic application, or for the production of pharmaceutical compositions, in particular dermopharmaceuticals.
Type:
Grant
Filed:
July 11, 2000
Date of Patent:
February 25, 2003
Assignee:
Coletica
Inventors:
Eric Perrier, Nicolas Terry, Delphine Rival, Anthony William Coleman
Abstract: A ceramide-like compound having properties of the natural ceramides are represented by the following formula (I), and a method for producing the same , and a cosmetic composition containing the same as an active ingredient:
Type:
Grant
Filed:
January 19, 2001
Date of Patent:
February 18, 2003
Assignee:
Pacific Corporation
Inventors:
Ho Sik Rho, Duck Hee Kim, Kil Joong Kim, Jae Won You, Hak Hee Kang, Ok Sub Lee, Jong Ho Park, Su Sun An, Eui Dong Son
Abstract: The hydroxystilbenes are well suited for reducing or inhibiting the glycation of certain substrates, for example the proteins of nails and/or hair, advantageously to preventatively and/or curatively combat glycation-related aging of the nails/hair.
Abstract: An endermic liniment which characteristically contains an extract from a plant of the Solanaceae family (Solanaceae), genus Withania (Withania). A whitening endermic liniment with a superior whitening effect can be provided.
Abstract: The invention relates to novel detergent cosmetic compositions comprising, in a cosmetically acceptable medium, at least one anionic surfactant chosen from 2-hydroxyalkyl ether carboxylic acid and salts thereof and at least one non-cellulosic cationic polymer the cationic charge density of which is greater than or equal to 2 meq/g. The invention also relates to processes for washing and/or treating keratin substances with the novel detergent cosmetic compositions.
Abstract: Novel pharmaceutically/cosmetically-active (poly)thiaalkynoic compounds have the structural formula (I):
R1—Y—CH2—C≡C—CH2—S—CH2—R2 (I)
and are useful for the treatment of a wide variety of disease states, whether human or veterinary, for example inflammation disorders, as well as for the treatment of mammalian skin and hair conditions/disorders.
Type:
Grant
Filed:
April 13, 2000
Date of Patent:
January 28, 2003
Assignee:
Societe L'Oreal S.A.
Inventors:
Jean Maignan, Sylvie Genard, Serge Michel
Abstract: Microbicidal compositions containing selected ratios of a non-halogenated 2-alkyl-3-isothiazolone and one or more (C1-C7) esters of para-hydroxybenzoic acid are disclosed as improved formulations for controlling microbial growth. In particular the combination of 2-methyl-3-isothiazolone with a mixture of methyl para-hydroxybenzoate and propyl para-hydroxybenzoate is especially effective as a microbicidal component in personal care compositions.
Type:
Grant
Filed:
April 12, 2001
Date of Patent:
January 28, 2003
Assignee:
Rohm and Haas Company
Inventors:
Li Liang Chia, Megan Anne Diehl, Christine Mary Schultz, Dolores Ann Shaw, Eileen Fleck Warwick, Terry Michael Williams
Abstract: A copolymer for cosmetics, which is obtained by polymerizing (A) 5 to 95% by weight of a fluorine-containing (meth)acrylate, and (B) 5 to 95% by weight of at least one fluorine-free monomer selected from the group consisting of (i) a silicone macromonomer, (ii) a polyalkylene glycol (meth)acrylate, (iii) an alkyl (meth)acrylate, and (iv) an alkyl (meth)acrylate macromonomer, can be easily incorporated in cosmetics and can form a film excellent in water resistance, water- and oil-repellency, feeling when used, and safety. This copolymer for cosmetics can improve the drawbacks of powder treated with a fluorine-containing compound.
Abstract: A process, composition, and kit for limiting the penetration into the skin and/or the keratinous fibers of at least one cosmetically and/or pharmaceutically active agent present in a base cosmetic and/or pharmaceutical composition for topical application and in particular for reducing the rate of penetration into the skin and/or the keratinous fibers of the active agent(s).
Abstract: Compositions which comprise sorbic acid and/or one or more sorbates, and a flavonoid and/or flavonoid derivative, a method for the preparation thereof, and their use.
Abstract: A process for making up or caring for keratin fibers. A composition comprising at least one film-forming polymer in the form of particles in aqueous dispersion, wherein the at least one film-forming polymer is chosen from polyurethanes, and fibers is applied to the keratin fibers. A cosmetic composition comprising at least one film-forming polymer in the form of particles in aqueous dispersion, wherein the at least one film-forming polymer is chosen from polyurethanes, at least one wax, and fibers, can also be applied to the keratin fibers.
Abstract: The invention concerns a compound selected among hyper-branched polymers and dendrimers, characterised in that it comprises at least one group of formula (I). The invention also concerns a method for preparing said compounds, and their use as thickening or gelling agent, in particular in cosmetics or pharmaceutics. The invention further concerns a cosmetic or pharmaceutical composition containing, in a cosmetically or pharmaceutically acceptable medium, said compounds.
Abstract: Methods for preventing or treating vascular hemorrhaging such as that incident to thrombolytic therapy, or characteristic of Alzheimer's and related diseases are provided. Such methods provide improved thrombolytic therapy to individuals who receive such therapy, and permit the diagnosis and treatment of diseases, such as Alzheimer's Disease, that are characterized by the deposition of amyloid deposits.
Abstract: Skin preparations for external use and cosmetics which contain a fermented soybean extract prepared by extracting with an organic solvent a fermentation product obtained by treating a soybean extract with one or more microorganisms selected from bifidobacteria. These preparations are excellent in the effects of relieving wrinkles and ameliorating rough skin.
Abstract: Improved formulations for detecting asthma are disclosed. The formulations comprise methacholine or histamine in a dry particulate form wherein the particles are of a respirable size, preferably 2 &mgr;m to 5 &mgr;m. The dry formulations can be inhaled directly from an inhaler and can be used to detect airway narrowing which is diagnostic of asthma.
Type:
Grant
Filed:
April 21, 2000
Date of Patent:
October 8, 2002
Assignee:
Ontario Inc.
Inventors:
Arthur Slutsky, Noe Zamel, Harold Wulffhart
Abstract: A novel cosmetic composition comprising a known hydroximic acid derivative as the active ingredient, and conventional carriers of the cosmetic composition are disclosed. The cosmetic composition of the invention is suitable for the prevention and/or reduction of the photoaging processes of the skin exposed to UV radiation.
Type:
Grant
Filed:
December 4, 1998
Date of Patent:
October 1, 2002
Assignee:
Medgene, Limited
Inventors:
Bea Farkas, Peter Literati Nagy, Agnes Vadasz, Laszlo Vigh